Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase III protocol for tesmilifene accepted by FDA

March 6, 2003

CG-53135 cleared to enter phase I trials

March 6, 2003

Phenoxodiol advances through clinical evaluation

March 5, 2003

Positive opinion in E.U. for long-term use of Zometa

March 5, 2003

Decitabine declared orphan drug for myelodysplastic syndrome in E.U.

March 5, 2003

Direct checkpoint activation: a novel anticancer strategy

March 5, 2003

New enediyne-based metal ligands with utility in cancer and viral infections

March 5, 2003

New antitumor agents in Pharma Mar development pipeline

March 5, 2003

New data on the safety and antitumor effects of ISIS-2503 plus gemcitabine in advanced solid tumors

March 4, 2003

Pharmacia describes inhibitors of beta-catenin/TCF-4 interaction and their use

March 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.